Study to Evaluate Effects of Vorinostat and HXTC on Persistent HIV-1 Infection in HIV-Infected Subjects Started on Antiretroviral Therapy (ART)

计划入组 17 人 · 首次发布于 2017 年 7 月 11 日

Phase I Study of HIV 1 Antigen Expanded Specific T Cell Therapy

计划入组 6 人 · 首次发布于 2014 年 8 月 4 日

Menopausal HT for Women Living With HIV (HoT)

计划入组 105 人 · 首次发布于 2025 年 3 月 4 日

HXTC-901

HX8

HXP-075

HLT, Inc.

United States

Hut 8 Corp

Canada

Hht Foundation International, Inc.

United States

ELLA AI Health Advocate Receives IRB Exemption, Advancing Ethical Clinical Trial Recruitment

FDA Clears HDT Bio's First-in-Class HDT-321 for Crimean-Congo Hemorrhagic Fever Prevention

HDT Bio Launches Canadian Phase 1 Trial of HDT-401, a Locally Administered RNA Immune Activator for Glioblastoma